The cell density within the marrow cavity in FGF2/Ara-C treated mice was higher than that from mice treated with Ara-C alone (Fig. 5, top and 2nd row), which was due to the increased number of leukemia cells (confirmed by CD45 staining, Fig. 5, 3rd and bottom row). Here, PTPRC is linked to leukemia.